14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
HHS vs HNI: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, HNI Corporation (HNI) is the stronger overall head-to-head candidate over Harte Hanks, Inc. (HHS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HHS carries a Unified Composite Score of 61.8/100 (BUY) at $3.84 (14.3x Forward P/E, -3.2% operating margin), whereas HNI carries 49.8/100 (HOLD) at $48.48 (10.3x Forward P/E, 6.6% operating margin).
Composite vs. Pillar Nuance: While HHS currently prints a higher short-term Unified Composite Score (61.8/100 BUY vs. HNI 49.8/100 HOLD), HNI captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (6.6% vs. -3.2% operating margin) and revenue trajectory (+132.9% vs. -1.7% YoY).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HHS vs HNI. Trailing 12-month operating profitability (HHS -3.2% vs HNI 6.6%) and valuation multiples (HHS 14.3x vs HNI 10.3x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Furnishings, Fixtures & Appliances value chain with $3.5B market capitalization and 6.6% operating margin.
OpEx & R&D Reinvestment35.5% of Rev ($744M)
90D Engineering Disclosures0 Published
Investor FAQ HHS vs HNI Key Questions & Quantitative Answers
As of Nov 16, 2026, HNI Corporation (HNI) is the stronger overall head-to-head candidate over Harte Hanks, Inc. (HHS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HHS carries a Unified Composite Score of 61.8/100 (BUY) at $3.84 (14.3x Forward P/E, -3.2% operating margin), whereas HNI carries 49.8/100 (HOLD) at $48.48 (10.3x Forward P/E, 6.6% operating margin). Composite vs. Pillar Nuance: While HHS currently prints a higher short-term Unified Composite Score (61.8/100 BUY vs. HNI 49.8/100 HOLD), HNI captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (6.6% vs. -3.2% operating margin) and revenue trajectory (+132.9% vs. -1.7% YoY).
HNI leads the Growth & Scale pillar: HHS posts -1.7% YoY revenue growth and -90.3% YoY earnings growth on $155M TTM revenue (16.1% gross margin, -3.2% operating margin), compared with HNI at +132.9% YoY revenue growth and +39.8% YoY earnings growth on $2.10B TTM revenue (42.1% gross margin, 6.6% operating margin). On trailing 12-month operating scale, HHS generates $155M in USD-normalized revenue versus $2.10B for HNI. In operating R&D and SG&A reinvestment, HHS deploys 19.3% of Rev ($30M) (0 90-day corporate R&D disclosures) versus 35.5% of Rev ($744M) (0 disclosures) for HNI.
HNI screens cheaper on headline valuation multiples. HHS trades at 14.3x Forward P/E, 14.3x Trailing P/E, 1.19x PEG, and 0.3x EV/Revenue (-2.9% FCF margin), whereas HNI trades at 10.3x Forward P/E, N/M Trailing P/E, 0.69x PEG, and 1.7x EV/Revenue (10.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HHS (-30.4% ROE) versus HNI (3.9% ROE) capital efficiency.
In options market volatility and institutional positioning, HHS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.49β · 46% Vol realized risk). By comparison, HNI carries 38.5% implied volatility (45th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.86β · 38% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.